GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 789 filers reported holding GLAXOSMITHKLINE PLC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $1,509,000 | -5.7% | 39,502 | -0.6% | 1.44% | +15.1% |
Q2 2018 | $1,601,000 | -2.6% | 39,727 | -5.6% | 1.25% | -5.6% |
Q1 2018 | $1,644,000 | +9.7% | 42,077 | -0.4% | 1.33% | +9.0% |
Q4 2017 | $1,498,000 | -12.6% | 42,229 | 0.0% | 1.22% | -12.1% |
Q3 2017 | $1,714,000 | -6.5% | 42,229 | -0.7% | 1.39% | -12.1% |
Q2 2017 | $1,834,000 | +2.3% | 42,529 | 0.0% | 1.58% | +13.4% |
Q1 2017 | $1,793,000 | +9.5% | 42,529 | 0.0% | 1.39% | +5.7% |
Q4 2016 | $1,638,000 | -10.7% | 42,529 | 0.0% | 1.32% | -10.8% |
Q3 2016 | $1,834,000 | +6.3% | 42,529 | +6.9% | 1.48% | +4.3% |
Q2 2016 | $1,725,000 | +7.4% | 39,800 | +0.5% | 1.41% | +1.5% |
Q1 2016 | $1,606,000 | +0.5% | 39,600 | 0.0% | 1.39% | -1.1% |
Q4 2015 | $1,598,000 | +2.2% | 39,600 | -2.6% | 1.41% | -4.0% |
Q3 2015 | $1,563,000 | -6.2% | 40,656 | +1.6% | 1.47% | +5.0% |
Q2 2015 | $1,667,000 | -10.0% | 40,031 | -0.2% | 1.40% | -11.9% |
Q1 2015 | $1,852,000 | +6.9% | 40,131 | -1.0% | 1.58% | +6.0% |
Q4 2014 | $1,732,000 | – | 40,531 | – | 1.50% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
OSTERWEIS CAPITAL MANAGEMENT INC | 1,948,915 | $79,029,000 | 4.59% |
Chubb Ltd | 400,000 | $16,220,000 | 4.42% |
Pegasus Partners Ltd. | 172,275 | $6,986,000 | 3.79% |
Keystone Financial Planning, Inc. | 117,762 | $4,775,000 | 3.42% |
P.R. Herzig & Co. Inc. | 36,950 | $1,498,000 | 3.28% |
Sterneck Capital Management, LLC | 112,535 | $4,563,000 | 3.21% |
Hamlin Capital Management, LLC | 1,454,031 | $58,961,000 | 2.98% |
Healthcare Value Capital, LLC | 50,000 | $2,028,000 | 2.98% |
Jolley Asset Management, LLC | 80,639 | $3,270,000 | 2.98% |
JFB Holdings Corp | 2,415,570 | $97,951,000 | 2.91% |